首页 | 本学科首页   官方微博 | 高级检索  
     

足月产后绒毛膜癌患者的临床特征与预后分析
引用本文:Lei CZ,Xiang Y,Wan XR,Yang JJ,Cui QC,Feng FZ,Yang XY. 足月产后绒毛膜癌患者的临床特征与预后分析[J]. 中华妇产科杂志, 2006, 41(11): 752-755
作者姓名:Lei CZ  Xiang Y  Wan XR  Yang JJ  Cui QC  Feng FZ  Yang XY
作者单位:1. 100730,中国医学科学院中国协和医科大学北京协和医院妇产科
2. 100730,中国医学科学院中国协和医科大学北京协和医院病理科
摘    要:
目的分析足月产后绒毛膜癌患者的临床特征、治疗和预后情况。方法回顾性分析了北京协和医院1985年12月至2005年6月间收治的103例足月产后绒毛膜癌患者的临床特征、治疗和预后情况。结果103例足月产后绒毛膜癌患者经过以化疗为主的综合治疗后,92例(89.3%)患者获得完全缓解,2例部分缓解,9例疾病进展死亡。92例完全缓解的患者中有4例复发,经过再次治疗3例完全缓解,1例死亡。103例患者中,25例出现耐药,经化疗或联合手术治疗后18例完全缓解,2例部分缓解,5例死亡。本组患者按2000年国际妇产科联盟(FIGO)标准,临床分期:Ⅰ期17例、Ⅱ期8例、Ⅲ期56例、Ⅳ期22例,各期的完全缓解率分别为100%、8/8、95%和64%,Ⅰ、Ⅱ、Ⅲ期的完全缓解率分别与Ⅳ期比较,差异均有统计学意义(P〈0.05);预后评分:低危型(预后评分≤6分)35例,高危型(预后评分≥7分)68例,其完全缓解率分别为100%和84%,两者比较,差异有统计学意义(P〈0.05)。结论提高足月产后绒毛膜癌的早期诊断率、采用联合化疗为主的多途径综合治疗、重视耐药和复发患者的治疗将明显提高足月产后绒毛膜癌的治愈率。

关 键 词:绒毛膜癌 产褥期 抗肿瘤联合化疗方案 预后
收稿时间:2006-06-05
修稿时间:2006-06-05

Clinical characters and prognosis of postpartum choriocarcinoma
Lei Cheng-Zhi,Xiang Yang,Wan Xi-Run,Yang Jun-Jun,Cui Quan-Cai,Feng Feng-Zhi,Yang Xiu-Yu. Clinical characters and prognosis of postpartum choriocarcinoma[J]. Chinese Journal of Obstetrics and Gynecology, 2006, 41(11): 752-755
Authors:Lei Cheng-Zhi  Xiang Yang  Wan Xi-Run  Yang Jun-Jun  Cui Quan-Cai  Feng Feng-Zhi  Yang Xiu-Yu
Affiliation:Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Belting 100730, China
Abstract:
OBJECTIVE: To analyze the clinical characters and prognosis of postpartum choriocarcinoma. METHODS: Retrospective analysis of 103 patients diagnosed with postpartum choriocarcinoma in Peking Union Medical College Hospital between 1985 and 2005 was performed. RESULTS: In a total of 103 cases of postpartum choriocarcinoma treated with multiagent cytotoxic chemotherapy and combined modality therapy, 92 patients (89.3%) achieved a complete remission while 2 patients had a partial remission, and 9 patients died. Regarding 25 cases with chemorefractory choriocarcinoma and 4 relapsed cases, 18 and 3 cases achieved a complete remission respectively. According to the new International Federation of Gynecology and Obstetrics (FIGO) 2000 staging and risk factor scoring system, 17 cases were at FIGO stage I, 8 cases at stage II, 56 cases at stage III, and 22 cases at stage IV. Complete remission was achieved in 100%, 8/8, 95% and 64% respectively. Thirty-five cases in low risk group had FIGO scores < or = 6, and all achieved a complete remission. Of 68 cases in high risk group with FIGO scores > or = 7, 57 (84%) of them obtained a complete remission. There were significant differences in the two groups (P < 0.05). CONCLUSION: Postpartum choriocarcinoma could have an increasing probability of cure with early diagnosis and the use of modern multiagent cytotoxic chemotherapy and combined modality therapy.
Keywords:Choriocarcinoma    Puerperium    Antineoplastic combined chemotherapy protocols    Prognosis
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号